EcoDrugPlus

Ensembl ID : ENSLACG00000006927
Gene Symbol: -
Cross references: -
189 Possible Orthologues:

Ensembl ID : ENSLACG00000008646
Gene Symbol: -
Cross references: -
130 Possible Orthologues:

Ensembl ID : ENSLACG00000007657
Gene Symbol: -
Cross references: -
175 Possible Orthologues:

Ensembl ID : ENSLACG00000007271
Gene Symbol: -
Cross references: -
284 Possible Orthologues:

Ensembl ID : ENSLACG00000007466
Gene Symbol: EGLN1
1 Cross references
234 Possible Orthologues:

Ensembl ID : ENSLACG00000005173
Gene Symbol: -
Cross references: -
193 Possible Orthologues:

Ensembl ID : ENSLACG00000001306
Gene Symbol: RPL13
1 Cross references
269 Possible Orthologues:

Ensembl ID : ENSLACG00000009023
Gene Symbol: -
Cross references: -
135 Possible Orthologues:

Ensembl ID : ENSLACG00000018745
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Ensembl ID : ENSLACG00000006251
Gene Symbol: RPL27
1 Cross references
370 Possible Orthologues:

Ensembl ID : ENSLACG00000014944
Gene Symbol: -
Cross references: -
313 Possible Orthologues:

Ensembl ID : ENSLACG00000016913
Gene Symbol: -
Cross references: -
16 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).